CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


Last Updated: August 26, 2010
Result type: Reports
Project Number: SR0208-000
Product Line: Reimbursement Review

Generic Name: Denosumab

Brand Name: Prolia

Manufacturer: Amgen Canada Inc.

Therapeutic Area: Osteoporosis, postmenopausal women

Indications: Osteoporosis, postmenopausal women

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: March 30, 2011

Recommendation Type: List with clinical criteria and/or conditions